We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$52.8B
AUM Growth
+$3.04B
Cap. Flow
+$773M
Cap. Flow %
1.47%
Top 10 Hldgs %
15.62%
Holding
3,462
New
204
Increased
1,543
Reduced
1,373
Closed
208
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMKR
3176
DELISTED
Emcore Corp
EMKR
$16.2K ﹤0.01%
1,406
-86
-6% -$1.05K
WKHS icon
3177
Workhorse Group
WKHS
$33.1M
$16.1K ﹤0.01%
4
-1
-20% -$5.52K
INTZ
3178
DELISTED
INTRUSION INC NEW
INTZ
$15.5K ﹤0.01%
13,249
PFIE
3179
DELISTED
Profire Energy, Inc
PFIE
$15.4K ﹤0.01%
+12,408
New +$14.3K
VIEW
3180
DELISTED
View, Inc. Class A Common Stock
VIEW
$15.2K ﹤0.01%
507
EMPD
3181
Empery Digital
EMPD
$79.6M
0
OUST icon
3182
Ouster
OUST
$3.25B
$15K ﹤0.01%
+1,791
New +$20.8K
URG
3183
Ur-Energy
URG
$533M
$14.8K ﹤0.01%
13,978
-3,600
-20% -$4.07K
VCSA
3184
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$14.5K ﹤0.01%
756
-9
-1% -$252
FIRY
3185
Firy Inc
FIRY
$158M
$14.4K ﹤0.01%
1,210
+142
+13% +$1.88K
CTXR icon
3186
Citius Pharmaceuticals
CTXR
$20.1M
$13K ﹤0.01%
444
BODI icon
3187
The Beachbody Company
BODI
$47.6M
$12.2K ﹤0.01%
506
+5
+1% +$155
THER
3188
DELISTED
THERATECHNOLOGIES INC COM
THER
$12.2K ﹤0.01%
15,048
+948
+7% +$768
GLMD icon
3189
Galmed Pharmaceuticals
GLMD
$4.39M
$11.9K ﹤0.01%
155
BGMS
3190
Bio Green Med Solution Inc
BGMS
$5.11M
$11.9K ﹤0.01%
6
GORO icon
3191
Goldgroup Mining Inc.
GORO
$211M
$11.6K ﹤0.01%
11,092
+783
+8% +$1K
OGI
3192
Organigram Holdings
OGI
$177M
$11.5K ﹤0.01%
4,496
-50
-1% -$159
CATX icon
3193
Perspective Therapeutics
CATX
$354M
$11.2K ﹤0.01%
1,750
DXYN
3194
DELISTED
Dixie Group Inc
DXYN
$11.1K ﹤0.01%
14,585
OCGN icon
3195
Ocugen
OCGN
$458M
$10.4K ﹤0.01%
12,193
GOEV
3196
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$10.3K ﹤0.01%
34
-1
-3% -$424
NXTP
3197
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$10.2K ﹤0.01%
10,089
-466
-4% -$917
SPPI
3198
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$9.53K ﹤0.01%
12,706
+203
+2% +$148
ASXC
3199
DELISTED
Asensus Surgical, Inc.
ASXC
$9.23K ﹤0.01%
14,033
+1,500
+12% +$1.02K
TCRT icon
3200
Alaunos Therapeutics
TCRT
$4.86M
$9.18K ﹤0.01%
97

Similar funds

Raymond James Financial Services Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James Financial Services Advisors held 3,462 positions worth $52.8B, up 6.1% from $49.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James Financial Services Advisors's Q1 2023 filing shows 204 new, 1,543 increased, 1,373 reduced and 208 closed positions. Its largest new stake was FT Vest US Equity Moderate Buffer ETF February: 2,000,342 shares worth $59.2M. The largest sale was MGP Ingredients, an estimated $333M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q1 2023 buy was FT Vest US Equity Moderate Buffer ETF February: 2,000,342 shares worth $59.2M.
  • Raymond James Financial Services Advisors added most to Amplify CWP Enhanced Dividend Income ETF in Q1 2023, an estimated $53.2M increase.
  • Raymond James Financial Services Advisors's biggest Q1 2023 reduction was MGP Ingredients, cutting an estimated $333M.
  • Raymond James Financial Services Advisors fully exited First Trust Mid Cap Value AlphaDEX Fund in Q1 2023, selling an estimated $9.15M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 16% of its $52.8B portfolio in Q1 2023.
  • Raymond James Financial Services Advisors opened 204 new positions and closed 208 in Q1 2023.
  • Raymond James Financial Services Advisors's portfolio value rose 6.1% quarter-over-quarter to $52.8B.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2023, filed 14 Apr 2023.